Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 2/20 | 0.33 |
| ▸ | RORC | P51449 | 3/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22822267 | 0.97 | KIF11 (0.39) | KIF11PDK2PTGER4RXRARXRG | |
| SCHEMBL19903594 | 0.96 | KIF11 (0.43) | KIF11PDK2RXRARXRGPDPK1 | |
| SCHEMBL19903608 | 0.94 | KIF11 (0.39) | KIF11PDK2RXRARXRGPDPK1 | |
| SCHEMBL19917822 | 0.94 | KIF11 (0.39) | KIF11PDK2PTGER4RXRARXRG | |
| SCHEMBL22822513 | 0.94 | RXRA (0.39) | KIF11PTGER4RXRARXRGPDPK1 | |
| SCHEMBL19903493 | 0.94 | TACR1 (0.34) | KIF11RXRARXRGTACR1 | |
| SCHEMBL19917926 | 0.94 | ICMT (0.35) | KIF11RXRARXRGTACR1RORC | |
| SCHEMBL22822414 | 0.93 | RXRA (0.40) | KIF11PDK2RXRARXRGTACR1 | |
| SCHEMBL19903580 | 0.93 | RXRA (0.38) | KIF11PTGER4RXRARXRGPDPK1 | |
| SCHEMBL22822144 | 0.93 | KIF11 (0.42) | KIF11PDK2RXRARXRGPDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-10-08 | — | — | US | disclosed |
| EP-3360945-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | CYNORA GMBH (DE) | 2019-04-24 | — | — | EP | disclosed |
| EP-3287450-B1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-03-20 | — | — | EP | disclosed |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| EP-3287450-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, ORC3, AOC3 | KIF11 3253/4885PDK2 3373/4885PTGER4 1093/4885 |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | KIF11 3316/4885PDK2 3319/4885PTGER4 993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.